SERIES B COMMON STOCK PURCHASE WARRANT APTEVO THERAPEUTICS INC.Aptevo Therapeutics Inc. • August 7th, 2023 • Pharmaceutical preparations
Company FiledAugust 7th, 2023 IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times on or after August 4, 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the eighteen (18) month anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Aptevo Therapeutics Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of common stock of the Company, par value $0.001 per share (the “Common Stock”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 7th, 2023 • Aptevo Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 7th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 1, 2023, between Aptevo Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Aptevo Therapeutics Inc.Aptevo Therapeutics Inc. • August 7th, 2023 • Pharmaceutical preparations • New York
Company FiledAugust 7th, 2023 Industry Jurisdiction